中文 | English
Return
Total: 97 , 1/10
Show Home Prev Next End page: GO
Author:(Xiao-Xuan ZHENG)

1.Apoptosis and expression of Fas, TNF-? and Bcl-2 in patients’serum and cerebrospinal fluid with HAM/TSP

Yingxiu XIAO ; Xuan ZHENG ;

Chinese Journal of Neurology 2000;0(04):-

2.Kinase modulators approved by FDA in 2022

Xuan ZHENG ; Xiao-yun LU

Acta Pharmaceutica Sinica 2024;58(1):61-75

3.Apoptosis and expression of Fas,TNF-? and Bcl-2 in HAM/TSP and its significance

Yingxiu XIAO ; Xuan ZHENG ; Weiduan ZHUANG

Journal of Clinical Neurology 1993;0(03):-

4.Effect of Probucol on Renal Cortex Blood Flow and Renal Function in Patients with Chronic Kidney Disease

Zhaoxiong HU ; Xuan ZHENG ; Houqin XIAO ; Pei FEI

Herald of Medicine 2014;(12):1584-1587

5.Analysis on pathogenic bacteria and drug sensitivity of canalicular inflammation

Xiao-Zhao, YANG ; Hua, YANG ; Xian-Ning, LIU ; Xuan, ZHENG ; Yi, ZHANG

International Eye Science 2016;16(10):1976-1977

8.Surface plasmon resonance biosensor technology and its application in biomedicine.

Xuan WENG ; Xiao-Lin ZHENG ; Jun YANG

Chinese Journal of Medical Instrumentation 2006;30(5):383-344

9.Prediction of malignant middle cerebral artery infarction by plasma MMP-9 and hsCRP level

Shunxiu WU ; Wen LI ; Lingling ZHANG ; Weiduan ZHUANG ; Xuan ZHENG ; Yingxiu XIAO ; Rongbo CHEN

Chinese Journal of Primary Medicine and Pharmacy 2010;17(10):1303-1305

10.Application and prospect of alkyl polyglycosides absorption enhancers in drug delivery system

Xian-fu LI ; Zhi-wei ZHANG ; Xiao-xuan HONG ; Xiao-lu HAN ; Meng LI ; Zeng-ming WANG ; Ai-ping ZHENG

Acta Pharmaceutica Sinica 2021;56(6):1591-1598

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 97 , 1/10 Show Home Prev Next End page: GO